Sun Pharmaceutical Industries has appointed Mr Israel Makov as Chairman of its board of directors, making clear the Mumbai-based drug-maker's global intentions.
Mr Makov was the former President and Chief Executive of Israeli generic drugs-major Teva Pharmaceutical Industries Ltd, between 2002 and 2007. He is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals, a statement from Sun said.
Mr Makov comes with the knowledge and experience of globalising businesses successfully, said Mr Dilip Shanghvi, Managing Director, Sun Pharma. “As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience,” he added.